Review of Intravitreal ranibizumab for symptomatic drusenoid pigment epithelial detachment without choroidal neovascularization in age-related macular degeneration | Publons

Log in Register

Post-publication Review of

Intravitreal ranibizumab for symptomatic drusenoid pigment epithelial detachment without choroidal neovascularization in age-related macular degeneration

Reviewed On June 17, 2017

Reviewed by

Actions

Content of review 1, reviewed on June 17, 2017

off Label VS LABEL USE OFlucentis and novel indications ? additional effects on RPE shown

Source

© 2017 the Reviewer (CC BY 4.0).